FIELD: chemistry.
SUBSTANCE: invention relates to the technology of producing biological preparations and can be used in the pharmaceutical industry. The method of preparing a pegylated human growth hormone involves pegylation of said protein with double-stranded polyethylene glycol in one site at pH not lower than 6.0. The obtained pegylated growth hormone is subjected to electrophoresis in polyacrylamide gel in non-reducing conditions, and separating the end product from a band which corresponds to a lower apparent molecular weight. The method, which involves pegylation of the human growth hormone at pH not lower than 8.0 and separating the obtained product, enables to obtain a preparation mainly containing pegylated human growth hormone with a lower apparent molecular weight. The pegylated growth hormone with a lower apparent molecular weight and a preparation rich in said hormone are used to prepare a medicament for treating diseases that require treatment with a growth hormone.
EFFECT: use of the invention increases biological activity of the growth hormone and prolongs its metabolic half-life.
19 cl, 24 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
POLYETHYLENE GLYCOL MODIFIED INTERFERON ALPHA 2B, PRODUCING AND USING PREPARATION | 2007 |
|
RU2485134C2 |
PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 2011 |
|
RU2575796C9 |
METHOD FOR PRODUCING A SUBSTANCE OF THE RECOMBINANT L-ASPARAGINASE FROM ERWINIA CAROTOVORA | 2010 |
|
RU2441914C1 |
CONJUGATION METHODS | 2010 |
|
RU2765240C2 |
ERYTHROPOETIN APPLICATION | 2003 |
|
RU2305554C2 |
METHOD OF CONTROLLING CONDITIONS FOR SITE-SPECIFIC BINDING OF POLYPEPTIDE AND NON-PEPTIDE POLYMER | 2010 |
|
RU2495881C2 |
METHODS OF CONJUGATION | 2010 |
|
RU2595424C2 |
VARIANT FORMS OF URATE OXIDASE AND USE THEREOF | 2012 |
|
RU2610680C9 |
NOVEL PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2281116C2 |
COVALENT MODIFICATION OF POLYPEPTIDES WITH POLYETHYLENE GLYCOLS | 1992 |
|
RU2148586C1 |
Authors
Dates
2013-07-27—Published
2008-04-03—Filed